Hubei Jumpcan Pharmaceutical Co Ltd (600566) — Cash Flow Quality Index
Hubei Jumpcan Pharmaceutical Co Ltd (600566) has a Cash Flow Quality Index of -0.82x as of September 2025. Operating cash flow of CN¥-243.75 Million is below net income of CN¥298.10 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Hubei Jumpcan Pharmaceutical Co Ltd (600566) cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Hubei Jumpcan Pharmaceutical Co Ltd Cash Flow Quality Index (2000–2025)
Historical Cash Flow Quality Index for Hubei Jumpcan Pharmaceutical Co Ltd across 25 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Hubei Jumpcan Pharmaceutical Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Hubei Jumpcan Pharmaceutical Co Ltd (2000–2025)
Year-by-year earnings quality comparison for Hubei Jumpcan Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see Hubei Jumpcan Pharmaceutical Co Ltd stock valuation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.67x | CN¥1.20 Billion | CN¥1.78 Billion | ▼ -21.4% |
| 2024 | 0.86x | CN¥2.18 Billion | CN¥2.54 Billion | ▼ -30.1% |
| 2023 | 1.23x | CN¥3.46 Billion | CN¥2.82 Billion | ▲ +1.7% |
| 2022 | 1.21x | CN¥2.62 Billion | CN¥2.17 Billion | ▲ +9.4% |
| 2021 | 1.10x | CN¥1.89 Billion | CN¥1.72 Billion | ▼ -20.9% |
| 2020 | 1.39x | CN¥1.78 Billion | CN¥1.28 Billion | ▲ +5.4% |
| 2019 | 1.32x | CN¥2.15 Billion | CN¥1.62 Billion | ▲ +30.7% |
| 2018 | 1.01x | CN¥1.71 Billion | CN¥1.69 Billion | ▲ +4.3% |
| 2017 | 0.97x | CN¥1.19 Billion | CN¥1.22 Billion | ▼ -0.6% |
| 2016 | 0.98x | CN¥913.10 Million | CN¥934.36 Million | ▲ +3.4% |
| 2015 | 0.94x | CN¥645.48 Million | CN¥683.12 Million | ▼ -20.3% |
| 2014 | 1.19x | CN¥616.11 Million | CN¥519.39 Million | ▲ +66.4% |
| 2013 | 0.71x | CN¥287.16 Million | CN¥402.72 Million | ▲ +1276.0% |
| 2011 | 0.05x | CN¥411.24K | CN¥7.94 Million | ▼ -99.1% |
| 2010 | 6.03x | CN¥51.13 Million | CN¥8.48 Million | ▲ +847.4% |
| 2009 | 0.64x | CN¥4.92 Million | CN¥7.73 Million | ▼ -76.8% |
| 2008 | 2.74x | CN¥23.05 Million | CN¥8.42 Million | ▼ -18.7% |
| 2007 | 3.37x | CN¥36.72 Million | CN¥10.90 Million | ▲ +610.4% |
| 2006 | 0.47x | CN¥4.24 Million | CN¥8.95 Million | ▼ -93.7% |
| 2005 | 7.49x | CN¥63.38 Million | CN¥8.46 Million | ▲ +248.0% |
| 2004 | -5.06x | CN¥-37.74 Million | CN¥7.45 Million | ▼ -1775.7% |
| 2003 | 0.30x | CN¥2.24 Million | CN¥7.42 Million | ▼ -80.9% |
| 2002 | 1.58x | CN¥22.00 Million | CN¥13.89 Million | ▲ +277.6% |
| 2001 | 0.42x | CN¥7.43 Million | CN¥17.70 Million | ▼ -74.3% |
| 2000 | 1.63x | CN¥23.73 Million | CN¥14.55 Million | — |